ClassID:

96829

C07K14/25 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia Shigella (G)

Recent Application in this class:
#1
20260144857
2026-05-28

SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF

#2
20260137765
2026-05-21

METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF

#3
20250215057
2025-07-03

Method for Preparing Outer Membrane Vesicles

#4
20250127888
2025-04-24

Immunogenic Fusion Peptides Including FC Fragment and a Non Toxic B Subunit of AB5 Toxin

#5
20240409589
2024-12-12

MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES

#6
20240360184
2024-10-31

DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS

#7
20240299522
2024-09-12

Methods and compositions related to the next generation vaccine

#8
20240252610
2024-08-01

A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA

#9
20240207399
2024-06-27

PD-L1-BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS

#10
20240115686
2024-04-11

SHIGELLA MULTI-EPITOPE FUSION ANTIGEN PROTEINS AND METHODS OF USE

#11
20240082404
2024-03-14

SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES, SHIGA TOXIN EFFECTOR SCAFFOLDS, AND CELL-TARGETING MOLECULES FOR SITE-SPECIFIC CONJUGATION

#12
20230357406
2023-11-09

CTLA-4 BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS AND USES THEREOF

#13
20230331785
2023-10-19

HER2-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS

#14
20220401568
2022-12-22

CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES

#15
20220354938
2022-11-10

CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES

#16
20220306702
2022-09-29

METHODS AND COMPOSITIONS FOR USE OF RECOMBINANT BACTERIAL EFFECTOR PROTEINS AS ANTI-INFLAMMATORY AGENTS

#17
20220306701
2022-09-29

MHC class I epitope delivering polypeptides

#18
20220306700
2022-09-29

PD-L1 BINDING PROTEINS COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CD8+ T CELL ANTIGENS

#19
20220281926
2022-09-08

DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CELL-TARGETING MOLECULES COMPRISING THE SAME

#20
20220275030
2022-09-01

De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals

#21
20220265804
2022-08-25

FUSION PROTEIN CAPABLE OF SELF-ASSEMBLING INTO PROTEIN NANOPARTICLES AND APPLICATION THEREOF

#22
20220233673
2022-07-28

METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF

#23
20220162271
2022-05-26

HER2-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS

#24
20220152213
2022-05-19

Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation

#25
20220125907
2022-04-28

Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of use

#26
20210324082
2021-10-21

PD-L1 TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS

#27
20210268085
2021-09-02

Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes

#28
20210253649
2021-08-19

De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same

#29
20210253648
2021-08-19

MHC class I epitope delivering polypeptides

#30
20210107951
2021-04-15

PEPTIDES, ESPECIALLY POLYPEPTIDES, PHAGE DISPLAY SCREENING METHOD AND ASSOCIATED MEANS, AND THEIR USES FOR RESEARCH AND BIOMEDICAL APPLICATIONS

#31
20210079098
2021-03-18

PD-L1 -binding molecules comprising Shiga toxin A subunit scaffolds

#32
20210079097
2021-03-18

PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds

#33
20210054033
2021-02-25

METHODS AND COMPOSITIONS FOR USE OF RECOMBINANT BACTERIAL EFFECTOR PROTEINS AS ANTI-INFLAMMATORY AGENTS

#34
20210040160
2021-02-11

HER2-targeting molecules comprising de-immunized, Shiga toxin A subunit scaffolds

#35
20210017512
2021-01-21

CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES

#36
20200038493
2020-02-06

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

#37
20200024312
2020-01-23

CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES

#38
20200002387
2020-01-02

CD20-BINDING IMMUNOTOXINS FOR INDUCING CELLULAR INTERNALIZATION AND METHODS USING SAME

#39
20190359657
2019-11-28

Multivalent CD20-binding molecules comprising Shiga toxin a subunit effector regions and enriched compositions thereof

#40
20190328860
2019-10-31

Cholera toxin chimera and its use as a staph vaccine

#41
20190153044
2019-05-23

MHC Class I Epitope Delivering Polypeptides

#42
20190099442
2019-04-04

Artificial invaplex formulated with deacylated lipopolysaccharide

#43
20190038679
2019-02-07

Methods and compositions relating to engineered microbial cells

#44
20180265553
2018-09-20

Vaccine antigen with increased immunogenicity

#45
20180264072
2018-09-20

Polypeptides comprising vinculin binding sites for the treatment of proliferation and/or adhesion related diseases

#46
20180258144
2018-09-13

CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES

#47
20180258143
2018-09-13

De-Immunized, Shiga Toxin A Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same

#48
20180057544
2018-03-01

Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof

#49
20170283471
2017-10-05

MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS

#50
20170275382
2017-09-28

Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof

#51
20170101636
2017-04-13

Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties

#52
20170028046
2017-02-02

Vaccine against colibacillosis

#53
20170015719
2017-01-19

CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTEREST

#54
20160362458
2016-12-15

Modified microbial toxin receptor for delivering agents into cells

#55
20160347798
2016-12-01

MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES AND CELL-TARGETED MOLECULES FOR DIRECT CELL KILLING AND IMMUNE STIMULATION VIA MHC CLASS I PRESENTATION AND METHODS REGARDING THE SAME

#56
20160340394
2016-11-24

DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS

#57
20160289632
2016-10-06

Hyperblebbing strains

#58
20160243210
2016-08-25

Methods and compositions based on Shiga toxin type 2 protein

#59
20160206713
2016-07-21

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

#60
20160068577
2016-03-10

CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES

#61
20160017047
2016-01-21

CD20-binding immunotoxins for inducing cellular internalization and methods using same

#62
20150259428
2015-09-17

CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same

#63
20150238591
2015-08-27

Multifunctional oral vaccine based on chromosome recombineering

#64
20150182610
2015-07-02

Live, oral vaccine for protection against serotype 1

#65
20150045536
2015-02-12

Universal carrier for targeting molecules to GB3 receptor expressing cells

#66
20140323700
2014-10-30

Recombinant N-glycosylated proteins from procaryotic cells

#67
20140220072
2014-08-07

-derived vector and methods of using the same

#68
20140120134
2014-05-01

Live, oral vaccine for protection against serotype 1

#69
20130210750
2013-08-15

Polypeptide TF1 for inhibiting type 2 Shiga toxin activity, encoding gene for same and use thereof

#70
20130156802
2013-06-20

Cholera toxin chimera and its use as a staph vaccine

#71
20130149329
2013-06-13

Broadly protective vaccine based on type III secretion apparatus proteins

#72
20130078274
2013-03-28

Live, oral vaccine for protection against serotype 1

#73
20130052227
2013-02-28

HYPERBLEBBING SHIGELLA STRAINS

#74
20120251542
2012-10-04

Ricin ribosome binding protein compositions and methods of use thereof

#75
20120040433
2012-02-16

Live, oral vaccine for protection against serotype 1

#76
20110318357
2011-12-29

Methods and compositions based on shiga toxin type 2 protein

#77
20110243914
2011-10-06

Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GBexpressing tumors

#78
20110231960
2011-09-22

Bacterial toxin vaccine

#79
20100329992
2010-12-30

Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors

#80
20100322913
2010-12-23

Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest

#81
20100298238
2010-11-25

NONTOXIC SHIGA-LIKE TOXIN MUTANT COMPOSITIONS AND METHODS

#82
20100291148
2010-11-18

Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens

#83
20100196418
2010-08-05

Universal carrier for targeting molecules to Gb3 receptor expressing cells

#84
20100196417
2010-08-05

Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells

#85
20100136045
2010-06-03

protein antigens and methods

#86
20100124556
2010-05-20

protein antigens and methods

#87
20100062484
2010-03-11

Recombinant N-glycosylated proteins from procaryotic cells

#88
20090203641
2009-08-13

Antibiotic compositions and related screening methods

#89
20090156417
2009-06-18

Library From Toxin Mutants, And Methods Of Using Same

#90
20090092578
2009-04-09

Methods of selecting and producing modified toxins, conjugates containing modified toxins, and uses thereof

#91
20080193486
2008-08-14

Live, oral vaccine for protection against serotype 1

#92
20080113405
2008-05-15

Gene-Cassette For Enhancement Of Protein Production

#93
20080107653
2008-05-08

Hybrid Shiga-like toxin

#94
20070298434
2007-12-27

Library of Toxin Mutants, and Methods of Using Same

#95
20070274994
2007-11-29

Virulence-Associated Adhesins

#96
20070128183
2007-06-07

Td antigens

#97
20060257940
2006-11-16

Transformed

#98
20060115493
2006-06-01

Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof

#99
20060030048
2006-02-09

Plasmid maintenance system for antigen delivery

#100
20060030047
2006-02-09

Plasmid maintenance system for antigen delivery

#101
20060029616
2006-02-09

Plasmid maintenance system for antigen delivery

#102
20060008475
2006-01-12

Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gbexpressing tumors

#103
20050153403
2005-07-14

Process for preparing L-amino acids using strains of the enterobacteriaceae family

#104
20050136070
2005-06-23

Isolation and characterization of the operon (ETEC-CS4 pili) and methods of using same

#105
20050031644
2005-02-10

Transformed

#106
20050003539
2005-01-06

Plasmid maintenance system for antigen delivery

#107
17314563
2022-07-19

Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation